ANAHEIM, Calif., Feb. 11, 2015 –Solvay, a leading global supplier of high-performance thermoplastics, and TSO3 Inc., a leading developer of low-temperature sterilization systems for the healthcare industry, jointly announced today that, as part of the U.S. FDA’s 510(k) premarket clearance for TSO3’s new STERIZONE® VP4 Sterilization System received in December 2014, light weight instrument trays made of Solvay Specialty Polymer’s Radel® polyphenylsulfone (PPSU) resin demonstrate strong compatibility for sterilizing a wide range of medical devices.
Log in to view full press release.